Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Depreciation Expense (2016 - 2018)

Fortress Biotech has reported Depreciation Expense over the past 3 years, most recently at $400000.0 for Q3 2018.

  • Quarterly results put Depreciation Expense at $400000.0 for Q3 2018, up 100.0% from a year ago — trailing twelve months through Sep 2018 was $846000.0 (up 15.26% YoY), and the annual figure for FY2017 was $700000.0, up 75.0%.
  • Depreciation Expense for Q3 2018 was $400000.0 at Fortress Biotech, up from $200000.0 in the prior quarter.
  • Over the last five years, Depreciation Expense for FBIO hit a ceiling of $400000.0 in Q3 2018 and a floor of -$119000.0 in Q4 2017.
  • Median Depreciation Expense over the past 3 years was $160000.0 (2016), compared with a mean of $154727.3.
  • Peak annual rise in Depreciation Expense hit 6750.0% in 2017, while the deepest fall reached 174.38% in 2017.
  • Fortress Biotech's Depreciation Expense stood at $160000.0 in 2016, then plummeted by 174.38% to -$119000.0 in 2017, then skyrocketed by 436.13% to $400000.0 in 2018.
  • The last three reported values for Depreciation Expense were $400000.0 (Q3 2018), $200000.0 (Q2 2018), and $365000.0 (Q1 2018) per Business Quant data.